EDP Sciences logo
Soumettre un article
rechercher
Menu
Accueil Tous les numéros Volume 19 / Numéro 4 (Juillet-Août 2012) OCL, 19 4 (2012) 228-231 Références
Open Access
Numéro
OCL
Volume 19, Numéro 4, Juillet-Août 2012
Page(s) 228 - 231
Section Dossier : Absorption intestinale des lipides
DOI https://doi.org/10.1051/ocl.2012.0463
Publié en ligne 15 juillet 2012
  • ANSES. Actualisation des apports nutritionnels conseillés pour les acides gras. Maisons-Alfort : ANSES, 2011. [Google Scholar]
  • Arem R, Ghusn H, Ellerhorst J, Comstock JP. Effect of decreased plasma low-density lipoprotein levels on adrenal and testicular function in man. Clin Biochem 1997 ; 30 : 419–424. [CrossRef] [PubMed] [Google Scholar]
  • Avigan MI, Ishak KG, Gregg RE, Hoofnagle JH. Morphologic features of the liver in abetalipoproteinemia. Hepatology 1984 ; 4 : 1223–1226. [CrossRef] [PubMed] [Google Scholar]
  • Bosner MS, Lange LG, Stenson WF, Ostlund RE Jr. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 1999 ; 40 : 302–308. [PubMed] [Google Scholar]
  • Chandler CE, Wilder DE, Pettini JL, et al. Cp-346086: An mtp inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res 2003 ; 44 : 1887–1901. [CrossRef] [PubMed] [Google Scholar]
  • Cohen JC, Boerwinkle E, Mosley TH, Jr, Hobbs HH. Sequence variations in pcsk9, low ldl, and protection against coronary heart disease. N Engl J Med 2006 ; 354 : 1264–1272. [CrossRef] [PubMed] [Google Scholar]
  • Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. Low ldl cholesterol in individuals of african descent resulting from frequent nonsense mutations in pcsk9. Nat Genet 2005 ; 37 : 161–165. [CrossRef] [PubMed] [Google Scholar]
  • Crooke RM, Graham MJ, Lemonidis KM, Whipple CP, Koo S, Perera RJ. An apolipoprotein b antisense oligonucleotide lowers ldl cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res 2005 ; 46 : 872–884. [CrossRef] [PubMed] [Google Scholar]
  • Elias N, Patterson BW, Schonfeld G. Decreased production rates of vldl triglycerides and apob-100 in subjects heterozygous for familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 1999 ; 19 : 2714–2721. [CrossRef] [PubMed] [Google Scholar]
  • Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the united states. Circulation 2009 ; 119 : 1108–1115. [CrossRef] [PubMed] [Google Scholar]
  • Fouchier SW, Sankatsing RR, Peter J, et al. High frequency of apob gene mutations causing familial hypobetalipoproteinaemia in patients of dutch and spanish descent. J Med Genet 2005 ; 42 : e23. [CrossRef] [PubMed] [Google Scholar]
  • Gauthier S, Sniderman A. Action tremor as a manifestation of chylomicron retention disease. Ann Neurol 1983 ; 14 : 591. [CrossRef] [PubMed] [Google Scholar]
  • Hercberg S, Preziosi P, Briancon S, et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The su.Vi.Max study–design, methods, and participant characteristics. Supplementation en vitamines et mineraux antioxydants. Control Clin Trials 1998 ; 19 : 336–351. [CrossRef] [PubMed] [Google Scholar]
  • Illingworth DR, Kenny TA, Orwoll ES. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J Clin Endocrinol Metab 1982 ; 54 : 27–33. [CrossRef] [PubMed] [Google Scholar]
  • Illingworth DR, Orwoll ES, Connor WE. Impaired cortisol secretion in abetalipoproteinemia. J Clin Endocrinol Metab 1980 ; 50 : 977–979. [CrossRef] [PubMed] [Google Scholar]
  • Jones B, Jones EL, Bonney SA, et al. Mutations in a sar1 gtpase of copii vesicles are associated with lipid absorption disorders. Nat Genet 2003 ; 34 : 29–31. [CrossRef] [PubMed] [Google Scholar]
  • Kim E, Campbell S, Schueller O, et al. A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, slx-4090: Biochemical, pharmacodynamic, pharmacokinetic, and safety profile. J Pharmacol Exp Ther 2011 ; 337 : 775–785. [CrossRef] [PubMed] [Google Scholar]
  • Lacaille F, Bratos M, Bouma ME, Jos J, Schmitz J, Rey J. Anderson’s disease. Clinical and morphologic study of 7 cases. Arch Fr Pediatr 1989 ; 46 : 491–498. [PubMed] [Google Scholar]
  • Lambert D, Daubrosse E, Steinmetz J, Siest G, Debry G. Reference values of plasma and lipoprotein cholesterol and triacylglycerols in healthy children. Arch Fr Pediatr 1984 ; 41 : 145–150. [PubMed] [Google Scholar]
  • Leppert M, Breslow JL, Wu L, et al. Inference of a molecular defect of apolipoprotein b in hypobetalipoproteinemia by linkage analysis in a large kindred. J Clin Invest 1988 ; 82 : 847–851. [CrossRef] [PubMed] [Google Scholar]
  • Muller DP, Lloyd JK, Bird AC. Long-term management of abetalipoproteinaemia. Possible role for vitamin e. Arch Dis Child 1977 ; 52 : 209–214. [CrossRef] [PubMed] [Google Scholar]
  • NIH. The lipid research clinics population studies data book. BETHESDA, National Heart and Lung Institute, 1980, 1. [Google Scholar]
  • Partin JS, Partin JC, Schubert WK, McAdams AJ. Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis. Gastroenterology 1974 ; 67 : 107–118. [PubMed] [Google Scholar]
  • Peretti N, Roy CC, Sassolas A, et al. Chylomicron retention disease: A long term study of two cohorts. Mol Genet Metab 2009 ; 97 : 136–142. [CrossRef] [PubMed] [Google Scholar]
  • Peretti N, Sassolas A, Roy CC, et al. Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. Orphanet J Rare Dis 2010 ; 5 : 24. [CrossRef] [PubMed] [Google Scholar]
  • Roy CC, Levy E, Green PH, et al. Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein b. Chylomicron retention disease. Gastroenterology 1987 ; 92 : 390–399. [PubMed] [Google Scholar]
  • Sankatsing RR, Fouchier SW, de Haan S, et al. Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 2005 ; 25 : 1979–1984. [CrossRef] [PubMed] [Google Scholar]
  • Schonfeld G, Patterson BW, Yablonskiy DA, et al. Fatty liver in familial hypobetalipoproteinemia: Triglyceride assembly into vldl particles is affected by the extent of hepatic steatosis. J Lipid Res 2003 ; 44 : 470–478. [CrossRef] [PubMed] [Google Scholar]
  • Sehayek E, Nath C, Heinemann T, et al. U-shape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans. J Lipid Res 1998 ; 39 : 2415–2422. [PubMed] [Google Scholar]
  • Silvain M, Bligny D, Aparicio T, et al. Anderson’s disease (chylomicron retention disease): A new mutation in the sara2 gene associated with muscular and cardiac abnormalities. Clin Genet 2008 ; 74 : 546–552. [CrossRef] [PubMed] [Google Scholar]
  • Strich D, Goldstein R, Phillips A, et al. Anderson’s disease: No linkage to the apo b locus. J Pediatr Gastroenterol Nutr 1993 ; 16 : 257–264. [CrossRef] [PubMed] [Google Scholar]
  • Tarugi P, Averna M. Hypobetalipoproteinemia: Genetics, biochemistry, and clinical spectrum. Adv Clin Chem 2011 ; 54 : 81–107. [CrossRef] [PubMed] [Google Scholar]
  • Traber MG, Sokol RJ, Ringel SP, Neville HE, Thellman CA, Kayden HJ. Lack of tocopherol in peripheral nerves of vitamin e-deficient patients with peripheral neuropathy. N Engl J Med 1987 ; 317 : 262–265. [CrossRef] [PubMed] [Google Scholar]
  • Wetterau JR, Aggerbeck LP, Bouma ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992 ; 258 : 999–1001. [CrossRef] [PubMed] [Google Scholar]
  • Wu J, Kim J, Li Q, et al. Known mutations of apob account for only a small minority of hypobetalipoproteinemia. J Lipid Res 1999 ; 40 : 955–959. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.